Global Research Effort Combines Social Applications with Advanced Online Healthcare

IBM"From the moment of birth, we take our place in the medical system. Sick or healthy - like it or not - we are part of it. Doesn't it make sense that we have some control over our role?"

These were some of the thoughts of IBM researchers, as they began work on the IBM Patient Empowerment System, a revolutionary patient portal. The system combines the basic features of other health portals, such as record storage and a procedure calendar, with new advanced technology that includes an elaborate adverse drug event (ADE) warning system and unique social applications.

Researchers from three corners of Asia - the IBM Ubiquitous Computing Laboratory in Korea, IBM Research - Haifa, and IBM Research - China came together for the collaboration. The portal was developed in cooperation with the Gacheon University Gil hospital in Korea, in an effort to increase efficiency and reduce costs at the million-patient facility. Other healthcare centers can easily adapt the system.

Differing medical systems in the three countries added unique challenges to the project, yet the developers discovered that concerns about healthcare are largely universal. Yossi Mesika, who leads the project at IBM Research - Haifa, explained, "People want to be involved. Just like they might go online to ensure that their banks don't make any errors in their accounts - they would like be better equipped to check that their care givers aren't missing anything or to prepare for an upcoming appointment. And they would like to do it in a secure way. Health systems simply work better when patients and doctors collaborate."

Taking charge of your health
Most of us already use the Internet as a tool for researching symptoms, but the enormous number of sources renders this time-consuming and sometimes more overwhelming than helpful. Moreover, gauging the credibility and accuracy of these sources can be difficult. Often we also must invest time in largely bureaucratic tasks - such as copying records for insurance approvals or second opinion consultations. More important tasks, like ensuring that our medications do not conflict, have been left to professionals. The IBM system addresses all of these issues and more.

"People use social media applications to connect with friends and family, but they don't generally use them to ask for medical advice or compare symptoms," adds Mesika. "Yet they probably would do this with a stranger in an appropriate setting - their doctor's waiting room or a medical-based chat room."

"The IBM portal infuses aspects of social media into a medical setting, providing a place for people to consult with one another. In addition to sharing information with connections they meet online, members can consult with their own doctors or with family or friends," remarks Young Ju Tak, project leader at the IBM Ubiquitous Computing Laboratory in Korea.

Helping doctors help patients
The portal invites people to create profiles and enter or import their records, including lab results, medications, allergies, genomic tests, and more. The system can aggregate information from various sources, such as monitoring devices, hospital systems, and other portals. In addition, members can enter multiple profiles - for their children or elderly parents, for example.

Physicians can use the system to connect with and monitor their patients and to interact with other providers and with the portal's greater community.

Access to their patients' daily monitoring enables them to see patterns that they might not otherwise discover. "Since the profiles can hold patients' entire histories, doctors get holistic views - which may include significant information that the patients themselves do not know to mention," adds Tak.

The ADE alert system serves as a safety net for patients who mix prescription with over-the-counter drugs, or who use more than one physician or pharmacist - situations known to increase the risk of errors. The portal also alerts against dosages that may not be appropriate for a patient's weight or condition.

Additionally, the IBM system helps protect members by incorporating data regarding pharmacogenetic interactions and warning those at risk. Some people have genetic variations that cause them to metabolize certain drugs differently than the general population. "Such variations go largely undiscovered until after a patient experiences a dangerous overdose-like reaction. Given that care providers are often unaware of their patients' genetic data, the portal fills a critical gap," explains Feng Cao, who leads the project at IBM Research - China.

Personalized medicine
The portal also serves as an information gateway, helping members sort through the onslaught of online data by providing the information most relevant for them.

Mesika sums up the portal's benefits: "The IBM Patient Empowerment System aims to bring the relationships among patients, their caregivers, and the online community at large to a new level of collaboration, without compromising privacy. For medical centers and insurers, this translates into lower costs, reduced medication errors, and faster treatment - all leading to satisfied customers."

Related news articles:

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...